Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
A Study to Evaluate Acalabrutinib, in Combination With the R-CHOP Standard of Care, for Previously Untreated Mantle Cell Lymphoma in Spain
ClinicalTrials.gov study NCT07029737. IPD Sharing: YES. Countries: 1. Publications: 0.
Chemotherapy Combined With Targeted Therapy as First-line Treatment for Mantle Cell Lymphoma Based on MRD and PET-CT Assessment
ClinicalTrials.gov study NCT07206264. IPD Sharing: NO. Countries: 1. Publications: 0.
SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00076349. IPD Sharing: Not stated. Countries: 3. Publications: 0.
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03585725. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00003541. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
ClinicalTrials.gov study NCT02488512. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04189757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India
ClinicalTrials.gov study NCT03476655. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety Study to Evaluate Induction and Consolidation Treatment in Patients With Mantle Cell Lymphoma (LCM-04-02)
ClinicalTrials.gov study NCT00505232. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).
ClinicalTrials.gov study NCT01389427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib Combined With R-CHOP/R-DHAP in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged ≤65 Years
ClinicalTrials.gov study NCT05429918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00033267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
131I-rituximab for Relapsed or Refractory Follicular or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01678417. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT04398953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab, Bortezomib,Bendamustine , Dexamethasone, Patients With Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00740415. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06084936. IPD Sharing: YES. Countries: 13. Publications: 0.
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04061850. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05976763. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT01170052. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib and Rituximab for the Treatment of Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04765111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.